H2O Innovation (OTCMKTS:HEOFF) and ThermoGenesisHoldingsInc . (NASDAQ:THMO) are both small-cap industrial products companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, analyst recommendations, valuation, profitability, earnings and dividends.
Earnings & Valuation
This table compares H2O Innovation and ThermoGenesisHoldingsInc .’s top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|H2O Innovation||$90.64 million||0.48||-$1.65 million||$0.02||38.90|
|ThermoGenesisHoldingsInc .||$9.67 million||0.86||-$39.72 million||($3.60)||-0.96|
This is a breakdown of current ratings for H2O Innovation and ThermoGenesisHoldingsInc ., as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Given ThermoGenesisHoldingsInc .’s higher probable upside, analysts clearly believe ThermoGenesisHoldingsInc . is more favorable than H2O Innovation.
This table compares H2O Innovation and ThermoGenesisHoldingsInc .’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Risk & Volatility
H2O Innovation has a beta of 0.25, meaning that its stock price is 75% less volatile than the S&P 500. Comparatively, ThermoGenesisHoldingsInc . has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500.
Institutional & Insider Ownership
4.6% of ThermoGenesisHoldingsInc . shares are owned by institutional investors. 68.9% of ThermoGenesisHoldingsInc . shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
H2O Innovation beats ThermoGenesisHoldingsInc . on 7 of the 12 factors compared between the two stocks.
About H2O Innovation
H2O Innovation Inc. provides integrated water treatment solutions based on membrane filtration technology in Canada, the United States, Spain, China, the United Arab Emirates, Mexico, France, Egypt, and internationally. It designs, manufactures, and markets systems and equipment for the production of drinking water and industrial process water, reclamation and reuse of water, and desalination of seawater and treatment of wastewater. The company also provides products, as well as membrane filtration systems' spare parts, such as pumps, valves, membranes, filters, media, and other replacement parts of water or wastewater treatment system; and specialty chemicals for membrane pre-treatment applications, as well as develops blends for maintenance, preservation, and cleaning of membrane systems. In addition, it offers specialty coagulants for conventional and membrane filtration systems, as well as flocculants; a line of couplings and fittings for industrial and municipal applications; cartridge filter housings, bag filters, strainers, and cartridge filter elements; and maple syrup products and equipment, such as evaporators, reverse osmosis separators, monitoring solutions, membranes, fittings, tubing, tanks, press filters, and other products related to the maple syrup industry. Further, the company provides operation and maintenance services for water and wastewater treatment systems; and public works services, which include street maintenance, drainage maintenance, and solid waste collection, as well as leases containerized water or wastewater treatment systems, and pilot units. It primarily serves municipalities and local governments; communities and private developments; energy and power plants; food and beverages industries; oil and gas markets; mining and workers camps; and other industrial segments. The company was founded in 2000 and is headquartered in Quebec City, Canada. H2O Innovation Inc. is a subsidiary of Amsterdams Effectenkantoor B.V.
About ThermoGenesisHoldingsInc .
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-based therapies in the United States, China, rest of Asia, Europe, and internationally. The company operates through two segments, Clinical Development and Device. It offers AutoXpress System, an automated system for the isolation, collection and storage of hematopoietic stem cell concentrates derived from cord blood and peripheral blood; Point-of CareXpress System for the rapid, automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells; CAR-TXpress System that addresses the critical unmet need for chemistry, manufacturing and controls improvement of the emerging CAR-T therapies for cancer patients; BioArchive Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing and cryogenic storage system for stem cell samples and clinical products; and manual disposables. The company is also developing autologous stem cell-based therapeutics that address medical needs for applications in the vascular, cardiology, and orthopedic markets. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was founded in 1986 and is headquartered in Rancho Cordova, California.
Receive News & Ratings for H2O Innovation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H2O Innovation and related companies with MarketBeat.com's FREE daily email newsletter.